Non-invasive diagnosis of colorectal cancer by Raman spectroscopy: Recent developments in liquid biopsy and endoscopy approaches

Spectrochim Acta A Mol Biomol Spectrosc. 2021 Sep 5:258:119818. doi: 10.1016/j.saa.2021.119818. Epub 2021 Apr 16.

Abstract

Colorectal cancer (CRC) is the third most common cancer diagnosed globally and is also one of the leading causes of cancer deaths in both men and women. The progression of CRC is slow and is often contained in colon but the risk increases with age. Based on the high certainty that the net benefit of screening in an age group is substantial, screening for CRC is recommended beginning at the age of 50. Currently, most of the incidence is concentrated in developed countries but the rate is increasing rapidly in developing geographies. Detecting CRC at an early stage is critical to reduce morbidity and mortality. Colonoscopy is the most preferred screening method but not very widely implemented due to practical considerations such as cost involved, lack of personnel and facility. To address these concerns, Raman spectroscopy (RS) has been suggested as a viable alternative due to its potential as a rapid non-invasive diagnostic tool. Recently, several studies have been reported but many variations of RS applications in CRC exists and are not well understood by non-specialists. This review focuses particularly on developments of Raman based liquid biopsy and endoscopic studies in order to throw light on each of their significance and limitations. Necessary developments in the future to translate RS into a clinical tool for screening and diagnosis of CRC are also briefly presented.

Keywords: Cancer; Colorectal cancer; Endoscopy; Liquid biopsy; Multivariate analysis; Non-invasive diagnosis; Raman spectroscopy.

Publication types

  • Review

MeSH terms

  • Colonic Neoplasms*
  • Colonoscopy
  • Colorectal Neoplasms* / diagnosis
  • Female
  • Humans
  • Liquid Biopsy
  • Male
  • Spectrum Analysis, Raman